Page last updated: 2024-10-31

mianserin and Erythremia

mianserin has been researched along with Erythremia in 2 studies

Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Verma, S1
Cikurel, K1
Koralnik, IJ1
Morgello, S1
Cunningham-Rundles, C1
Weinstein, ZR1
Bergmann, C1
Simpson, DM1
Focosi, D1
Kast, RE1
Maggi, F1
Lauria, G1
Ceccherini-Nelli, L1
Petrini, M1

Other Studies

2 other studies available for mianserin and Erythremia

ArticleYear
Mirtazapine in progressive multifocal leukoencephalopathy associated with polycythemia vera.
    The Journal of infectious diseases, 2007, Sep-01, Volume: 196, Issue:5

    Topics: Female; Humans; Leukoencephalopathy, Progressive Multifocal; Mianserin; Middle Aged; Mirtazapine; Po

2007
5-HT2a inhibitors for progressive multifocal leukoencephalopathy: old drugs for an old disease.
    The Journal of infectious diseases, 2008, Jan-15, Volume: 197, Issue:2

    Topics: Adult; Female; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Male; Mianserin; Middl

2008